Passer au contenu principal

Chemical Entities of Biological Interest Ontology (CHEBI)

Choisissez le vocabulaire dans lequel chercher

aligner
annoter
télécharger

Concept information

... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > organonitrogen compound > organonitrogen heterocyclic compound > pyridines > linkable imatinib analogue
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > heteroorganic entity > organonitrogen compound > organonitrogen heterocyclic compound > pyridines > linkable imatinib analogue
... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > heterocyclic compound > organic heterocyclic compound > organonitrogen heterocyclic compound > pyridines > linkable imatinib analogue
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > organic molecule > organic cyclic compound > organic heterocyclic compound > organonitrogen heterocyclic compound > pyridines > linkable imatinib analogue
... > chemical entity > molecular entity > polyatomic entity > molecule > organic molecule > organic cyclic compound > organic heterocyclic compound > organonitrogen heterocyclic compound > pyridines > linkable imatinib analogue
... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > organic cyclic compound > organic heterocyclic compound > organonitrogen heterocyclic compound > pyridines > linkable imatinib analogue
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > heteroorganic entity > organic heterocyclic compound > organonitrogen heterocyclic compound > pyridines > linkable imatinib analogue
... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > heterocyclic compound > organic heterocyclic compound > organic heteromonocyclic compound > pyridines > linkable imatinib analogue
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > organic molecule > organic cyclic compound > organic heterocyclic compound > organic heteromonocyclic compound > pyridines > linkable imatinib analogue
... > chemical entity > molecular entity > polyatomic entity > molecule > organic molecule > organic cyclic compound > organic heterocyclic compound > organic heteromonocyclic compound > pyridines > linkable imatinib analogue
... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > organic cyclic compound > organic heterocyclic compound > organic heteromonocyclic compound > pyridines > linkable imatinib analogue
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > heteroorganic entity > organic heterocyclic compound > organic heteromonocyclic compound > pyridines > linkable imatinib analogue
... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > monocyclic compound > heteromonocyclic compound > organic heteromonocyclic compound > pyridines > linkable imatinib analogue
... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > heterocyclic compound > heteromonocyclic compound > organic heteromonocyclic compound > pyridines > linkable imatinib analogue
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > organonitrogen compound > organonitrogen heterocyclic compound > diazines > pyrimidines > linkable imatinib analogue
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > heteroorganic entity > organonitrogen compound > organonitrogen heterocyclic compound > diazines > pyrimidines > linkable imatinib analogue
... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > heterocyclic compound > organic heterocyclic compound > organonitrogen heterocyclic compound > diazines > pyrimidines > linkable imatinib analogue
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > organic molecule > organic cyclic compound > organic heterocyclic compound > organonitrogen heterocyclic compound > diazines > pyrimidines > linkable imatinib analogue
... > chemical entity > molecular entity > polyatomic entity > molecule > organic molecule > organic cyclic compound > organic heterocyclic compound > organonitrogen heterocyclic compound > diazines > pyrimidines > linkable imatinib analogue
... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > organic cyclic compound > organic heterocyclic compound > organonitrogen heterocyclic compound > diazines > pyrimidines > linkable imatinib analogue
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > heteroorganic entity > organic heterocyclic compound > organonitrogen heterocyclic compound > diazines > pyrimidines > linkable imatinib analogue
... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > heterocyclic compound > organic heterocyclic compound > organic heteromonocyclic compound > diazines > pyrimidines > linkable imatinib analogue
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > organic molecule > organic cyclic compound > organic heterocyclic compound > organic heteromonocyclic compound > diazines > pyrimidines > linkable imatinib analogue
... > chemical entity > molecular entity > polyatomic entity > molecule > organic molecule > organic cyclic compound > organic heterocyclic compound > organic heteromonocyclic compound > diazines > pyrimidines > linkable imatinib analogue
... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > organic cyclic compound > organic heterocyclic compound > organic heteromonocyclic compound > diazines > pyrimidines > linkable imatinib analogue
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > heteroorganic entity > organic heterocyclic compound > organic heteromonocyclic compound > diazines > pyrimidines > linkable imatinib analogue
... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > monocyclic compound > heteromonocyclic compound > organic heteromonocyclic compound > diazines > pyrimidines > linkable imatinib analogue
... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > heterocyclic compound > heteromonocyclic compound > organic heteromonocyclic compound > diazines > pyrimidines > linkable imatinib analogue
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > organonitrogen compound > organonitrogen heterocyclic compound > piperazines > N-alkylpiperazine > linkable imatinib analogue
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > heteroorganic entity > organonitrogen compound > organonitrogen heterocyclic compound > piperazines > N-alkylpiperazine > linkable imatinib analogue
... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > heterocyclic compound > organic heterocyclic compound > organonitrogen heterocyclic compound > piperazines > N-alkylpiperazine > linkable imatinib analogue
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > organic molecule > organic cyclic compound > organic heterocyclic compound > organonitrogen heterocyclic compound > piperazines > N-alkylpiperazine > linkable imatinib analogue
... > chemical entity > molecular entity > polyatomic entity > molecule > organic molecule > organic cyclic compound > organic heterocyclic compound > organonitrogen heterocyclic compound > piperazines > N-alkylpiperazine > linkable imatinib analogue
... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > organic cyclic compound > organic heterocyclic compound > organonitrogen heterocyclic compound > piperazines > N-alkylpiperazine > linkable imatinib analogue
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > heteroorganic entity > organic heterocyclic compound > organonitrogen heterocyclic compound > piperazines > N-alkylpiperazine > linkable imatinib analogue
... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > heterocyclic compound > organic heterocyclic compound > organic heteromonocyclic compound > piperazines > N-alkylpiperazine > linkable imatinib analogue
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > organic molecule > organic cyclic compound > organic heterocyclic compound > organic heteromonocyclic compound > piperazines > N-alkylpiperazine > linkable imatinib analogue
... > chemical entity > molecular entity > polyatomic entity > molecule > organic molecule > organic cyclic compound > organic heterocyclic compound > organic heteromonocyclic compound > piperazines > N-alkylpiperazine > linkable imatinib analogue
... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > organic cyclic compound > organic heterocyclic compound > organic heteromonocyclic compound > piperazines > N-alkylpiperazine > linkable imatinib analogue
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > heteroorganic entity > organic heterocyclic compound > organic heteromonocyclic compound > piperazines > N-alkylpiperazine > linkable imatinib analogue
... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > monocyclic compound > heteromonocyclic compound > organic heteromonocyclic compound > piperazines > N-alkylpiperazine > linkable imatinib analogue
... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > heterocyclic compound > heteromonocyclic compound > organic heteromonocyclic compound > piperazines > N-alkylpiperazine > linkable imatinib analogue
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > organic amino compound > tertiary amino compound > N-alkylpiperazine > linkable imatinib analogue
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > organonitrogen compound > organic amino compound > tertiary amino compound > N-alkylpiperazine > linkable imatinib analogue
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > heteroorganic entity > organonitrogen compound > organic amino compound > tertiary amino compound > N-alkylpiperazine > linkable imatinib analogue

Terme préférentiel

linkable imatinib analogue  

Concept générique

Synonyme(s)

  • 4-{[4-(2-aminoethyl)piperazin-1-yl]methyl}-N-{4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]phenyl}benzamide

Appartient au groupe

URI

http://data.loterre.fr/ark:/67375/KFP-XH1DP4MV-9

Télécharger ce concept :

RDF/XML TURTLE JSON-LD